Patents by Inventor William Hook

William Hook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6689824
    Abstract: Sets of prepaints useful for forming a road-marking paint line are provided. Also provided are methods which permit the person applying the road-marking paint to vary the properties of the road-marking paint at the application point to suit the ambient conditions, including temperature, humidity, traffic flow and the like.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: February 10, 2004
    Assignee: Rohm and Haas Company
    Inventors: John Michael Friel, John William Hook, III, Bernhard Helmut Lieser, Jerry William Washel, Dennis Paul Lorah, Donald Craig Schall, Ann Robertson Hermes
  • Patent number: 6613832
    Abstract: Sets of fluid premixes useful for adhesives and caulks are provided. Also provided are methods of providing adhesive lines and a caulk lines using the sets of premixes. Further provided are ranges of adhesives and caulks based on the adhesive and caulk lines. Utilizing these methods the manufacturer, seller, or user can to adjust the adhesive or caulk at the point of manufacture, sale, or use to suit the processing and end-use conditions, in addition to the other benefits offered by delayed product differentiation.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: September 2, 2003
    Assignee: Rohm and Haas Company
    Inventors: John Michael Friel, John William Hook, III, Jerry William Washel, Dennis Paul Lorah, James Alexander Costanzo
  • Publication number: 20030110101
    Abstract: A paint manufacturing method includes receiving each of a group of fluid prepaints at different inputs of a fluid component mixing system, determining at a computer system a first fluid prepaint ratio, and mixing the fluid prepaints in accordance with the first ratio to form a base paint at an output of the mixing system. A paint manufacturing system includes a computer-controlled prepaint mixing system. The prepaint mixing system includes multiple fluid inputs providing for computer-controllable flow of prepaints into the mixing system. The computer system includes a memory storing software instructions that configured the computer system to receive user input selecting a base paint to be produced, determine a ratio of fluid prepaints needed to produce the base paint, and regulate each fluid flow control to establish, in the determined ratio, a flow of fluid prepaints entering the fluid mixing system.
    Type: Application
    Filed: January 19, 2001
    Publication date: June 12, 2003
    Inventors: John Michael Friel, John William Hook, Jerry William Washel, Bernhard Helmut Lieser
  • Patent number: 6531537
    Abstract: Methods of providing a paint line containing a latex polymeric binder are described. A range of paints can be formulated using sets of prepaints, at least one of which contains a latex polymeric binder. The paints may be applied as architectural coatings, industrial coatings, graphic arts coating, elastomeric coatings, and non-cementitious, aggregate finish coatings suitable for application on a wall directly or as a topcoat in exterior insulation finishing systems.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: March 11, 2003
    Inventors: John Michael Friel, John William Hook, III, Bernhard Helmut Lieser, Jerry William Washel, Dennis Paul Lorah, Joseph Michael Beno, Jr., Irene May Melly
  • Publication number: 20020055615
    Abstract: The methods of the present invention demonstrate that adrenomedullin (AM) is expressed in human cancer cell lines of diverse origin and functions as a universal autocrine growth factor driving neoplastic proliferation. The present invention provides for Tpeptides and AM antibodies useful in therapeutic, pharmacologic and physiologic compositions. The present invention additionally provides for methods of diagnosis, treatment and prevention of disease utilizing compositions comprising the AM peptides and antibodies of the present invention. The methods of the present invention also provide for experimental models for use in identifying the role of AM in pancreatic physiology. The methods pertaining to rat isolated islets have shown that AM inhibits insulin secretion in a dose-dependent manner. The monoclonal antibody MoAb-G6, which neutralizes AM bioactivity, was shown by the methods of the present invention to increase insulin release fivefold, an effect that was reversed by the addition of synthetic AM.
    Type: Application
    Filed: August 16, 2001
    Publication date: May 9, 2002
    Inventors: Frank Cuttitta, Alfredo Martinez, Mae Jean Miller, Edward J. Unsworth, William Hook, Thomas Walsh, Karen Gray, Charles Macri
  • Publication number: 20020016405
    Abstract: The preparation of a paint line using sets of prepaints containing a latex polymer binder. At least one of which contains a latex polymeric binder, is also is described. The paints may be applied to architectural coatings, and non-cementitious, aggregate finish coating suitable for application on a wall directly or as a topcoat.
    Type: Application
    Filed: February 16, 2001
    Publication date: February 7, 2002
    Inventors: John Michael Friel, John William Hook, Bernhard Helmut Lieser, Jerry William Washel, David Goodro Kelly
  • Publication number: 20020013401
    Abstract: Methods of providing a paint line containing a latex polymeric binder are described. A range of paints can be formulated using sets of prepaints, at least one of which contains a latex polymeric binder. The paints may be applied as architectural coatings, industrial coatings, graphic arts coating, elastomeric coatings, and non-cementitious, aggregate finish coatings suitable for application on a wall directly or as a topcoat in exterior insulation finishing systems.
    Type: Application
    Filed: February 16, 2001
    Publication date: January 31, 2002
    Inventors: John Michael Friel, John William Hook, Bernhard Helmut Lieser, Jerry William Washel, Dennis Paul Lorah, Joseph Michael Beno, Irene May Melly
  • Publication number: 20020004551
    Abstract: Sets of fluid premixes useful for adhesives and caulks are provided. Also provided are methods of providing adhesive lines and a caulk lines using the sets of premixes. Further provided are ranges of adhesives and caulks based on the adhesive and caulk lines. Utilizing these methods the manufacturer, seller, or user can to adjust the adhesive or caulk at the point of manufacture, sale, or use to suit the processing and end-use conditions, in addition to the other benefits offered by delayed product differentiation.
    Type: Application
    Filed: February 16, 2001
    Publication date: January 10, 2002
    Inventors: John Michael Friel, John William Hook, Jerry William Washel, Dennis Paul Lorah, James Alexander Costanzo
  • Publication number: 20010050030
    Abstract: Sets of prepaints useful for forming a road-marking paint line are provided. Also provided are methods which permit the person applying the road-marking paint to vary the properties of the road-marking paint at the application point to suit the ambient conditions, including temperature, humidity, traffic flow and the like.
    Type: Application
    Filed: February 16, 2001
    Publication date: December 13, 2001
    Inventors: John Michael Friel, John William Hook, Bernhard Helmut Lieser, Jerry William Washel, Dennis Paul Lorah, Donald Craig Schall, Ann Robertson Hermes
  • Patent number: 6320022
    Abstract: The methods of the present invention demonstrate that adrenomedullin (AM) is expressed in human cancer cell lines of diverse origin and functions as a universal autocrine growth factor driving neoplastic proliferation. The present invention provides for AM peptides and AM antibodies useful in therapeutic, pharmacologic and physiologic compositions. The present invention additionally provides for methods of diagnosis, treatment and prevention of disease utilizing compositions comprising the AM peptides and antibodies of the present invention. The methods of the present invention also provide for experimental models for use in identifying the role of AM in pancreatic physiology. The methods pertaining to rat isolated islets have shown that AM inhibits insulin secretion in a dose-dependent manner. The monoclonal antibody MoAb-G6, which neutralizes AM bioactivity, was shown by the methods of the present invention to increase insulin release fivefold, an effect that was reversed by the addition of synthetic AM.
    Type: Grant
    Filed: February 17, 1998
    Date of Patent: November 20, 2001
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Frank Cutitta, Alfredo Martinez, Mae Jean Miller, Edward J. Unsworth, William Hook, Thomas Walsh, Karen Gray, Charles Macri